Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 March;64(1) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 March;64(1):131-8

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE   

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 March;64(1):131-8

DOI: 10.23736/S1824-4785.18.03031-5

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Prognostic impact of postoperative 123I-metaiodobenzylguanidine scintigraphy: added value of SPECT/CT and semiquantification of the uptake at the surgical site

Mathieu GAUTHÉ 1, 2 , Matthieu BRETON 1, Nina JEHANNO 1, Cécile CELLIER 3, Jean MICHON 4, Sabine SARNACKI 5, Gudrun SCHLEIERMACHER 3, Myriam WARTSKI 1

 

ACCESS OPTIONS

You can access the full text of this article (PDF and HTML if available) for 48 hours at a price of  € 45,00.

Downloading and printing for personal use allowed.

Regain access


Access as an individual subscriber


Access through your institution

Subscribe to The Quarterly Journal of Nuclear Medicine and Molecular Imaging


Recommend to your librarian

top of page